Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1987 1
1988 3
1989 3
1990 2
1991 3
1992 6
1993 4
1994 3
1995 8
1996 5
1997 8
1999 6
2000 3
2001 2
2002 2
2003 3
2004 8
2005 6
2006 5
2007 3
2008 5
2009 1
2010 3
2011 5
2012 4
2013 2
2014 2
2015 2
2016 9
2017 2
2018 4
2019 4
2020 2
2021 12
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network.
Soussain C, Choquet S, Blonski M, Leclercq D, Houillier C, Rezai K, Bijou F, Houot R, Boyle E, Gressin R, Nicolas-Virelizier E, Barrie M, Moluçon-Chabrot C, Lelez ML, Clavert A, Coisy S, Leruez S, Touitou V, Cassoux N, Daniau M, Ertault de la Bretonnière M, El Yamani A, Ghesquières H, Hoang-Xuan K. Soussain C, et al. Among authors: rezai k. Eur J Cancer. 2019 Aug;117:121-130. doi: 10.1016/j.ejca.2019.05.024. Epub 2019 Jul 3. Eur J Cancer. 2019. PMID: 31279304 Clinical Trial.
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey).
Sharma A, Holz FG, Regillo CD, Freund KB, Sarraf D, Khanani AM, Baumal C, Holekamp N, Tadayoni R, Kumar N, Parachuri N, Kuppermann BD; International Retina Biosimilar Study Group (Inter BIOS Group); International Retina Biosimilar Study Group (Inter BIOS Group); Bandello F, Querques G, Loewenstein A, Özdek Ş, Rezai K, Laurent K, Bilgic A, Lanzetta P, Zur D, Yannuzzi N, Corradetti G, Kaiser P, Hilely A, Boyer D, Rachitskaya A, Chakravarthy U, Wintergerst M, Sarao V, Parolini B, Mruthyunjaya P, Nguyen QD, Do D, Keane PA, Hassan T, Sridhar J, Eichenbaum D, Grewal D, Splitzer M. Sharma A, et al. Among authors: rezai k. Expert Opin Biol Ther. 2023 Jul-Dec;23(8):851-859. doi: 10.1080/14712598.2023.2176218. Epub 2023 Feb 19. Expert Opin Biol Ther. 2023. PMID: 36726203
Pancreatic transplant imaging.
Yuh WT, Wiese JA, Abu-Yousef MM, Rezai K, Sato Y, Berbaum KS, Kao SC, Hunsicker LG, Corry RJ. Yuh WT, et al. Among authors: rezai k. Radiology. 1988 Jun;167(3):679-83. doi: 10.1148/radiology.167.3.3283838. Radiology. 1988. PMID: 3283838
Q fever: a biological weapon in your backyard.
Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Madariaga MG, et al. Among authors: rezai k. Lancet Infect Dis. 2003 Nov;3(11):709-21. doi: 10.1016/s1473-3099(03)00804-1. Lancet Infect Dis. 2003. PMID: 14592601 Review.
Tamoxifen therapy in a murine model of myotubular myopathy.
Maani N, Sabha N, Rezai K, Ramani A, Groom L, Eltayeb N, Mavandadnejad F, Pang A, Russo G, Brudno M, Haucke V, Dirksen RT, Dowling JJ. Maani N, et al. Among authors: rezai k. Nat Commun. 2018 Nov 19;9(1):4849. doi: 10.1038/s41467-018-07057-5. Nat Commun. 2018. PMID: 30451841 Free PMC article.
Are IPL home devices really foolproof?
Schmitt L, Rezai K, Karsai S. Schmitt L, et al. Among authors: rezai k. J Eur Acad Dermatol Venereol. 2016 May;30(5):856-7. doi: 10.1111/jdv.13025. Epub 2015 Feb 24. J Eur Acad Dermatol Venereol. 2016. PMID: 25712139 No abstract available.
142 results